Our shares trade on AIM and the Nasdaq Global Market. More detailed share information is provided below.
Summit is listed on AIM, a market of the London Stock Exchange, and the Nasdaq Global Market. More detailed share information is provided below.
|Issued share capital:||160,389,881|
|Ordinary Shares:||1p nominal value|
The percentage of Ordinary Shares not being held in public hands is 62.3%. Shares held in treasury: Nil Ordinary shares. There are no restrictions on the transfer of Ordinary Shares
in the Company.
|Shares Listed:||Ordinary Shares|
|Index||FTSE AIM All Share|
|Sector:||Pharmaceutical & Biotechnology|
|Shares Listed:||American Depositary Shares (ADS)|
|Market:||NASDAQ Global Market|
|Depositary Bank:||Bank of New York Mellon|
Each ADS represents five Ordinary Shares.
Information correct as at 15 February 2019
Summit had been notified of the following holdings of more than 3% or more of the issued share capital of the Company
|Robert W. Duggan||48.8%|
|Lansdowne Partners Limited||13.2%|
Information reviewed on 15 February 2019